TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/24/22 17:14 | 5/23/22 | PHAS | Phasebio Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Burkhardt Glen | PA | O | SVP of H | S | -9 | 0.7900 | 0 | -11 | -100 | 0 | D | ||||||||||||||
11/23/21 18:50 | 11/19/21 | PHAS | Phasebio Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Burkhardt Glen | PA | O | VP,HR | S | -14 | 2.37 | 0 | -6 | -100 | 0 | D | ||||||||||||||
5/24/21 18:11 | 5/20/21 | PHAS | Phasebio Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Burkhardt Glen | PA | O | VP,HR | S | -13 | 3.29 | 0 | -4 | -100 | 0 | D | ||||||||||||||
11/23/20 18:27 | 11/23/20 | PHAS | Phasebio Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Burkhardt Glen | PA | O | VP,HR | S | -12 | 3.45 | 0 | -3 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |